Study of Alpha Radioligand Therapy AB001 in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)

Clinical trial NCT07214961 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07214961
Sponsor: ARTBIO Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Prostate Cancer (CRPC)Metastatic Castrate Resistant Prostate Cancer (mCRPC)

Start date: 2025-11-03
Primary completion: 2027-11-03
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.